New York State Common Retirement Fund Tyme Technologies, Inc. Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 02, 2021	SELL	$0.99 - $1.38 $616 - $859	-623 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$1.14 - $1.87 $42,609 - $69,894	-37,377 Reduced 98.36%	623 $1,000
Q1 2021 May 11, 2021	BUY	$1.34 - $3.53 $33,098 - $87,191	24,700 Added 185.71%	38,000 $68,000
Q2 2019 Aug 09, 2019	SELL	$0.96 - $1.89 $86,496 - $170,289	-90,100 Reduced 87.14%	13,300 $16,000
Q1 2019 May 08, 2019	BUY	$1.76 - $3.73 $146,960 - $311,455	83,500 Added 419.6%	103,400 $182,000
Q2 2018 Aug 10, 2018	BUY	$2.05 - $4.09 $40,795 - $81,391	19,900 New	19,900 $63,000

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.